Open Access. Powered by Scholars. Published by Universities.®
Articles 1 - 1 of 1
Full-Text Articles in Bioinformatics
Exploration Of Potential Natural Inhibitors Against Kras-G12d In Pancan: Protein Centered Pharmacophore Htvs Approach., Anupam Dhasmana, Swati Dhasmana, Sudhir Kotnala, Vivek Kumar Kashyap, Sheema Khan, Murali M. Yallapu, Meena Jaggi, Subhash C. Chuahan
Exploration Of Potential Natural Inhibitors Against Kras-G12d In Pancan: Protein Centered Pharmacophore Htvs Approach., Anupam Dhasmana, Swati Dhasmana, Sudhir Kotnala, Vivek Kumar Kashyap, Sheema Khan, Murali M. Yallapu, Meena Jaggi, Subhash C. Chuahan
Research Symposium
Background: As per key statistics of American Cancer Society 2021, Pancreatic Cancer (PanCan) affects around 60,430 persons a year in the U.S. and is tricky to diagnose & treat. Studies revealed that African Americans have a 50–90% higher incidence of PanCan compared to other ethnic groups. Oncogenic KRAS mutation is the signature genetic incident in the progression and development of PDAC. KRAS is the most common protein which is 95% times mutated in PDAC condition. By considering this alarming situation our group is now focused on to develop therapeutic portfolio against KRAS-G12D mutation associated PanCan by using high through-put virtual …